ClinicalTrials.gov
ClinicalTrials.gov Menu

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02214160
Recruitment Status : Enrolling by invitation
First Posted : August 12, 2014
Last Update Posted : December 13, 2018
Sponsor:
Information provided by (Responsible Party):
Ultragenyx Pharmaceutical Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : September 2021
  Estimated Study Completion Date : September 2021